The folate receptor β as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis

Durga M S H Chandrupatla1, Carla F M Molthoff2, Adriaan A Lammertsma2

  • 1Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

Insights

Macrophages are crucial in rheumatoid arthritis (RA) and can be targeted for imaging and drug delivery. Folate receptor β (FRβ) on macrophages offers a promising avenue for RA diagnosis and treatment strategies.

Area of Science:

  • Immunology
  • Biochemistry
  • Radiology

Background:

  • Macrophages are central to rheumatoid arthritis (RA) pathophysiology.
  • Synovial macrophage infiltration correlates with RA disease activity and treatment outcomes.
  • Macrophages represent a viable target for RA imaging and drug delivery.

Purpose of the Study:

  • To review the emerging applications of Folate receptor β (FRβ) in rheumatoid arthritis.
  • To discuss FRβ properties, expression in relation to macrophage polarization, and its utility in imaging and drug targeting.

Main Methods:

  • Review of scientific literature on FRβ and its role in RA.
  • Discussion of FRβ expression patterns on myeloid cells and activated macrophages.
  • Analysis of FRβ-targeted imaging modalities and drug delivery systems.

Main Results:

  • FRβ is expressed on activated macrophages in RA.
  • FRβ's high affinity for folic acid enables targeted imaging (PET tracers) and therapy (drug conjugates).
  • Emerging applications leverage FRβ for in vivo imaging and drug delivery in RA.

Conclusions:

  • FRβ is a promising target for RA management.
  • Targeting FRβ can enhance disease imaging and therapeutic interventions in rheumatoid arthritis.
  • Further research into FRβ-directed strategies holds potential for improved RA patient outcomes.

Related Concept Videos

Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
111.0K
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.9K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.2K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.7K